Skip to content
DataLookout
Menu

HK inno.N Corporation clinical trial pipeline

Get alerts when HK inno.N Corporation's trials change
Data updated daily from ClinicalTrials.gov, last refresh 2026-11-19

What changed in the last 30 days

1 trial changed in the last 30 days: 0 stopped, 0 with notable changes, 1 with a minor change only.

  1. Minor: DFS and OS of Adjuvant FOLFIRINOX Regimen in Pancreatic Cancer Patients Enrollment closed, study ongoing HK inno.N CorporationNot specified NCT06389552
  • Stopped: terminated, suspended or withdrawn
  • Notable: the plan changed
  • Minor: routine updates

New trial filings, last 30 days

First postedTrialPhaseStatus
2026-11-12 NCT07930247 Blood Pressure Control and Safety of Ex-one or Ex-one Plus in Essential Hypertension Recruiting
2026-11-12 NCT07930260 Efficacy and Safety of Kabalin Cap.(Pregabalin) in Patients With Neuropathic Pain Recruiting
2026-11-10 NCT07930169 Observational Study to Evaluate the Safety and Efficacy of Kremezin IDT/Fine Gran in… Recruiting
2026-11-09 NCT07924345 Observational Study to Evaluate Achieving LDL-cholesterol Target Level to Treat With… Recruiting
2026-11-06 NCT07920679 Efficacy and Safety of K-CAB(Tegoprazan) 25 mg as Maintenance Therapy Following the… Recruiting

Active trials by phase

Phase 1
5
Phase 2
2
Phase 3
2
Phase 4
1
Not charted: 7 active trials with no phase listed on ClinicalTrials.gov (typically behavioural, device, procedure and observational studies).

Disease areas by active trials

Get alerts when HK inno.N Corporation's trials change
Status changes, date slips, and new filings: detected daily, delivered to your inbox.
Start monitoring free